{
    "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v2.0/OSP_Qualification_Plan_Schema.json",
    "Projects": [
        {
            "Id":  "Gabapentin rough",
            "Path":  "Models/Gabapentin.json",
            "BuildingBlocks": [],
            "SimulationParameters": []
        },
        {
            "Id":  "Acebutolol rough",
            "Path":  "Models/Acebutolol.json",
            "BuildingBlocks": [],
            "SimulationParameters": []
        },
        {
            "Id":  "Atenolol rough",
            "Path":  "Models/Atenolol_mod.json",
            "BuildingBlocks": [],
            "SimulationParameters": []
        }      
    ],
    "ObservedDataSets": [],
    "Plots": {
        "AxesSettings": {},
        "PlotSettings": {},
        "AllPlots": [
            {
                "Project": "Gabapentin rough",
                "Simulation": "Blum Healthy 400 mg PO",
                "SectionId": 311
            },
            {
                "Project": "Gabapentin rough",
                "Simulation": "Blum CKD3 400 mg PO",
                "SectionId": 312
            },
            {
                "Project": "Gabapentin rough",
                "Simulation": "Blum CKD5 400 mg PO",
                "SectionId": 312
            },
            {
                "Project": "Acebutolol rough",
                "Simulation": "Roux Healthy 200 mg PO",
                "SectionId": 321
            },
            {
                "Project": "Acebutolol rough",
                "Simulation": "Roux CKD 200 mg PO",
                "SectionId": 322
            },
            {
                "Project": "Atenolol rough",
                "Simulation": "Wan Population 50mg PO",
                "SectionId": 331
            },
            {
                "Project": "Atenolol rough",
                "Simulation": "Wan Population 100mg PO",
                "SectionId": 331
            },
            {
                "Project": "Atenolol rough",
                "Simulation": "Kirch 1980 Stage 3 Pop",
                "SectionId": 332
            },
            {
                "Project": "Atenolol rough",
                "Simulation": "Kirch 1980 Stage 4 Pop",
                "SectionId": 332
            },
            {
                "Project": "Atenolol rough",
                "Simulation": "Kirch 1980 Stage 5 Pop",
                "SectionId": 332
            },
            {
                "Project": "Atenolol rough",
                "Simulation": "Sassard Stage 3 Pop 100mg PO",
                "SectionId": 332
            },
            {
                "Project": "Atenolol rough",
                "Simulation": "Sassard Stage 4 Pop 100mg PO",
                "SectionId": 332
            }         
        ],
        "GOFMergedPlots": [],
        "ComparisonTimeProfilePlots": [],
        "DDIRatioPlots": [],
        "PKRatioPlots": []
    },
    "Inputs": [],
    "Sections": [
        {
            "Id": 1,
            "Title": "1 Introduction",
            "Content": "Content/Section1_Introduction.md"
        },
        {
            "Id": 2,
            "Title": "2 CKP Population Development",
            "Content": "Content/Section2_Model.md"
        },
        {
            "Id": 3,
            "Title": "3 Compounds",
            "Content": "Content/Section3_Results_and_Discussion.md",
            "Sections": [
                {
                    "Id": 31,
                    "Title": "3.1 Gabapentin",
                    "Content": "Content/Gabapentin_Introduction.md",
                    "Sections": [
                        {
                            "Id": 311,
                            "Title": "3.1.1 Gabapentin in a Healthy Population",
                            "Content": "Content/Gabapentin_healthy.md"
                        },
                        {
                            "Id": 312,
                            "Title": "3.1.2 Gabapentin in a CKD Population",
                            "Content": "Content/Gabapentin_CKD.md"
                        }
                    ]
                },
                {
                    "Id": 32,
                    "Title": "3.2 Acebutolol",
                    "Content": "Content/Acebutolol_Introduction.md",
                    "Sections": [
                        {
                            "Id": 321,
                            "Title": "3.2.1 Acebutolol in a Healthy Population",
                            "Content": "Content/Acebutolol_healthy.md"
                        },
                        {
                            "Id": 322,
                            "Title": "3.2.2 Acebutolol in a CKD Population",
                            "Content": "Content/Acebutolol_CKD.md"
                        }
                    ]
                },
                {
                    "Id": 33,
                    "Title": "3.3 Atenolol",
                    "Content": "Content/Atenolol_Introduction.md",
                    "Sections": [
                        {
                            "Id": 331,
                            "Title": "3.3.1 Atenolol in a Healthy Population",
                            "Content": "Content/Atenolol_healthy.md"
                        },
                        {
                            "Id": 332,
                            "Title": "3.3.2 Atenolol in a CKD Population",
                            "Content": "Content/Atenolol_CKD.md"
                        }
                    ]
                }
            ]
        },
        {
            "Id": 5,
            "Title": "5 References",
            "Content": "Content/References.md"
        }
    ],
    "Intro": []
}